InMed Pharmaceuticals Inc. announced the appointment of Joshua Blacher as Chief Business Officer.  In this capacity, Mr. Blacher will be focusing on raising the Company's visibility in the broader capital markets community, especially in the United States, as well as executing strategic finance initiatives and business development. Mr. Blacher joins in the company with twenty years of leadership experience in senior positions in the healthcare and capital markets sectors in the United States. Before joining in the company, Mr. Blacher served as Chief Financial Officer at Therapix Biosciences and Galmed Pharmaceuticals, where he focused on strategic finance, business development, and managing relations with the investment community.